Business Scope :
Providing R&D and production of RSMs & API for global pharmaceutical companies
Professional research institute
80 scientists with professional background and experience providing process R&D from route design, optimization to full CMC support and chemical synthetic solutions such as chiral synthesis, heterocycle chemistry, continuous flow chemistry and photochemistry with comprehensive analytic instruments (HPLC, LCMS, HRMS, NMR, RM, ICP-MS, TGA, Marvin granulometer, ICS etc.) and Safety & Risk assessment laboratory (Mettler DCS, Mettler RC 1e, THT ARC)
Massive production Plant
6 chemical synthesis workshops, 1 hydrogenation workshop, and 5 API GMP workshops (2 under construction); 326 reactors including 33pcs 10000L , 101pcs 5000L , 65pcs 3000L, 2 Hastelloy reactors.
EHS Infrastructure
covering an area of 16,500m2 including a 500 mt/d waste-water treatment station, 2 waste gas incinerators(RTO), 1 waste liquid incinerator (VR) and DCS&SIS
CDMO / CMO of small molecular chemical API and intermediates
The CDMO project of the company is led by Dr. Guoqiang Shi, a national high-level talent and a “Thousand Talents in Zhejiang Province”, responsible for high value-added projects with high technical requirements and difficult process development. After years of accumulation, the company has the ability to undertake various CDMO projects with high technology content, and the main techniques and capabilities are as follows: